3 Undervalued Pharmaceuticals Stocks for Monday, March 25
Discover the top 3 undervalued Pharmaceuticals stocks for Monday, March 25 based on AAII’s Stock Grades.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico. It is involved in medical cannabis cultivation, manufacturing, and sale; and leasing and/or rental of fiber optic networks and telecommunication towers. The company is based in Toronto, Canada.
Commentary & Analysis
Is Akanda Corp (AKAN) Stock a Good Investment?
Learn more about Akanda Corp's (AKAN) stock grades for Growth and determine whether this Pharmaceuticals stock meets your investment needs.Jenna Brashear
Financial Summary
| Share Statistics | AKAN | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $4.2 | $579.1 | 3% |
|
| Shares Out (Mil) | 0.1 | 43.0 | 1% |
|
| Institutional Ownership | 15.1% | 84.3% | 9% |
|
| Float (Mil) | 0.5 | 46.8 | 1% |
|
| Beta | na | 0.62 | na |
|
| Avg Daily Volume (000s) | 665 | 285 | 64% |
|
| Price Change (52-week) |
(93.6%) | 63.8% | 3% |
|
| Growth | AKAN | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 6.7% | na |
|
| Net Income (5yr) | (81.8%) | (1.4%) | 3% |
|
| EPS (5yr) | na | 14.9% | na |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (14.9%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | AKAN | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $0 | $272 | 1% |
|
| Net Income (TTM) (Mil) | ($46) | ($11) | 17% |
|
| EPS (TTM) | ($662.218) | ($0.500) | 0% |
|
| Operating Cash Flow (TTM) (Mil) | ($7) | ($6) | 23% |
|
| Net Cash Flow (TTM) (Mil) | ($3) | $4 | 36% |
|
| Long-Term Debt (Q1) (Mil) | $12 | $7 | 29% |
|
| Enterprise Value (Q1) (Mil) | $19 | $522 | 10% |
|
| Valuation | AKAN | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.73 | na |
|
| P/E | na | 20.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | AKAN | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | (60.5%) | 65.9% | 2% |
|
| Net Margin | na | 0.7% | na |
|
| ROA | (647.1%) | (24.6%) | 0% |
|
| ROE | na | (19.7%) | na |
|
| Liabilities to Assets | 293.5% | 35.5% | 99% |
|
| F-Score | 1 | 3 | na |
|
Akanda Corp. did not pass any screens on 7/31/2026.
